Reactions Weekly

, Volume 937, Issue 1, pp 3–3

US FDA guidance requires pharmaceutical companies to integrate race and ethnicity data into clinical trial analyses

Guideline

DOI: 10.2165/00128415-200309370-00008

Cite this article as:
React. Wkly. (2003) 937: 3. doi:10.2165/00128415-200309370-00008

Copyright information

© Adis International limited or Adis Data Information BV 2003